Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it is expanding its mRNA pipeline with three new development...
The Pharmasyntez Group of companies is going to launch the parenteral (intravenous) nutrition department in Primorye.
At a meeting with Oleg Kozhemyako, Governor of Primorsky...
The Takeda Pharmaceutical Co-led group that is developing a blood plasma treatment for COVID-19 has started manufacturing while the late-stage trial to determine whether...
No serious adverse effects detected during Sputnik M trials, Health Ministry says.
Clinical trials of the Sputnik M vaccine against coronavirus for teens aged 12-17...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), R-Pharm group and AstraZeneca announce interim results of phase II clinical trials to evaluate...